Related Experiment Videos
P16/MTS1 and pRB expression in endometrial carcinomas
K Milde-Langosch1, L Riethdorf, A M Bamberger
1Department of Gynecopathology, Institute of Pathology, University Clinics Eppendorf, Hamburg, Germany.
Abstract:
p16MTS1/CDKN1 and the retinoblastoma protein Rb are both involved in negative regulation of G1/S progression in the mammalian cell cycle. Inactivation of one of these tumour suppressor genes is involved in many malignant tumours, and in some studies a negative correlation of p16 and Rb expression has been found. In order to study this interaction in endometrial carcinogenesis, we investigated 36 endometrial carcinomas, 11 cases of hyperplasia, 23 normal endometrial samples, and two uterine carcinoma cell lines by immunohistochemistry or RT-PCR. Rb was expressed in normal endometrial epithelium, hyperplasia, cell lines, and most carcinomas; negative immunostaining was only detected in 1 of 36 tumours. In contrast, p16 expression was weak in normal endometrium and increased in most cases of hyperplasia, but negative or minimally positive in 74% of the carcinomas and the Hec1B adenocarcinoma cell line, and there was no significant association with Rb immunostaining. Strikingly high p16 expression was found in foci of squamous metaplasia within hyperplastic or carcinomatous tissue. Deletion and mutation analysis of the p16 gene was performed in DNA from microdissected tumour samples and cell lines. No p16 deletion was found, and mutations were detected in only one tumour sample and Skut1B uterine mixed mesodermal tumour cells. Our data indicate that in spite of low or absent p16 expression, genetic alterations of the p16 and Rb tumour suppressor genes are rare in endometrial carcinogenesis.
Insights
p16 and retinoblastoma protein (Rb) regulate cell cycle progression. This study found low p16 expression in most endometrial carcinomas, with rare genetic alterations in p16 and Rb, suggesting they are not primary drivers of endometrial cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- p16MTS1/CDKN1 and retinoblastoma protein (Rb) are tumor suppressors regulating G1/S phase transition.
- Inactivation of p16 or Rb is common in malignancies, with some studies suggesting an inverse correlation in expression.
- Understanding the interplay of p16 and Rb is crucial in endometrial carcinogenesis.
Purpose of the Study:
- To investigate the interaction and expression patterns of p16 and Rb in endometrial carcinogenesis.
- To determine the frequency of genetic alterations in p16 and Rb during endometrial cancer development.
Main Methods:
- Immunohistochemistry and RT-PCR were used to assess p16 and Rb expression in endometrial tissues and cell lines.
- Deletion and mutation analyses of the p16 gene were performed on microdissected tumor samples and cell lines.
Main Results:
- Rb was widely expressed in normal endometrium, hyperplasia, and most carcinomas.
- p16 expression was low in normal endometrium, increased in hyperplasia, but was negative or minimally positive in 74% of carcinomas.
- No significant association was found between p16 and Rb immunostaining; p16 gene deletions or mutations were rare in endometrial tumors.
Conclusions:
- Genetic alterations of p16 and Rb are infrequent in endometrial carcinogenesis despite typically low p16 expression in tumors.
- The study suggests that p16 and Rb may not be the primary drivers of endometrial carcinogenesis, though their roles in specific contexts like squamous metaplasia warrant further investigation.